<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27312068</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><PubDate><Year>2016</Year><Month>Jun</Month><Day>17</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>The polyglutamine-expanded androgen receptor responsible for spinal and bulbar muscular atrophy inhibits the APC/C(Cdh1) ubiquitin ligase complex.</ArticleTitle><Pagination><StartPage>27703</StartPage><MedlinePgn>27703</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">27703</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep27703</ELocationID><Abstract><AbstractText>Polyglutamine expansion in the androgen receptor (AR) causes spinal and bulbar muscular atrophy (SBMA), an X-linked neuromuscular disease that is fully manifest only in males. It has been suggested that proteins with expanded polyglutamine tracts impair ubiquitin-dependent proteolysis due to their propensity to aggregate, but recent studies indicate that the overall activity of the ubiquitin-proteasome system is preserved in SBMA models. Here we report that AR selectively interferes with the function of the ubiquitin ligase anaphase-promoting complex/cyclosome (APC/C), which, together with its substrate adaptor Cdh1, is critical for cell cycle arrest and neuronal architecture. We show that both wild-type and mutant AR physically interact with the APC/C(Cdh1) complex in a ligand-dependent fashion without being targeted for proteasomal degradation. Inhibition of APC/C(Cdh1) by mutant but not wild-type AR in PC12 cells results in enhanced neurite outgrowth which is typically followed by rapid neurite retraction and mitotic entry. Our data indicate a role of AR in neuronal differentiation through regulation of APC/C(Cdh1) and suggest abnormal cell cycle reactivation as a pathogenic mechanism in SBMA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bott</LastName><ForeName>Laura C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm 17177, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Neurological Disorders and Stroke, Neurogenetics Branch, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salomons</LastName><ForeName>Florian A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm 17177, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maric</LastName><ForeName>Dragan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Flow Cytometry Core Facility, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yuhong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merry</LastName><ForeName>Diane</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischbeck</LastName><ForeName>Kenneth H</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>National Institute of Neurological Disorders and Stroke, Neurogenetics Branch, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dantuma</LastName><ForeName>Nico P</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm 17177, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ZIA NS003037</GrantID><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>06</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015703">Antigens, CD</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C513384">CDH1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015820">Cadherins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D064173">Anaphase-Promoting Complex-Cyclosome</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D064173" MajorTopicYN="N">Anaphase-Promoting Complex-Cyclosome</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015703" MajorTopicYN="N">Antigens, CD</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015820" MajorTopicYN="N">Cadherins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002453" MajorTopicYN="N">Cell Cycle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016501" MajorTopicYN="N">Neurites</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016716" MajorTopicYN="N">PC12 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059748" MajorTopicYN="N">Proteolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="N">Receptors, Androgen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27312068</ArticleId><ArticleId IdType="pmc">PMC4911547</ArticleId><ArticleId IdType="doi">10.1038/srep27703</ArticleId><ArticleId IdType="pii">srep27703</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kennedy W. R., Alter M. &amp; Sung J. H. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 18, 671&#x2013;680 (1968).</Citation><ArticleIdList><ArticleId IdType="pubmed">4233749</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada A. R., Wilson E. M., Lubahn D. B., Harding A. E. &amp; Fischbeck K. H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77&#x2013;79 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr H. T. &amp; Zoghbi H. Y. Trinucleotide repeat disorders. Annu. Rev. Neurosci. 30, 575&#x2013;621 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17417937</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves-Rodrigues A., Gregori L. &amp; Figueiredo-Pereira M. E. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci. 21, 516&#x2013;520 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9881849</ArticleId></ArticleIdList></Reference><Reference><Citation>Perutz M. F. Glutamine repeats and neurodegenerative diseases: molecular aspects. Trends Biochem. Sci 24, 58&#x2013;63 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10098399</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman M. Y. &amp; Goldberg A. L. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29, 15&#x2013;32 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11182078</ArticleId></ArticleIdList></Reference><Reference><Citation>Hershko A. &amp; Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67, 425&#x2013;479 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9759494</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciechanover A. &amp; Brundin P. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40, 427&#x2013;446 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14556719</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinnon C. &amp; Tabrizi S. J. The ubiquitin-proteasome system in neurodegeneration. Antioxid. Redox Signal. 21, 2302&#x2013;2321 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24437518</ArticleId></ArticleIdList></Reference><Reference><Citation>Bence N. F., Sampat R. M. &amp; Kopito R. R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552&#x2013;1555 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11375494</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokui K. et al. 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse. Hum. Mol. Genet. 18, 898&#x2013;910 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19066230</ArticleId></ArticleIdList></Reference><Reference><Citation>Bett J. S., Cook C., Petrucelli L. &amp; Bates G. P. The ubiquitin-proteasome reporter GFPu does not accumulate in neurons of the R6/2 transgenic mouse model of Huntington&#x2019;s disease. PLoS One 4, e5128 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2662425</ArticleId><ArticleId IdType="pubmed">19352500</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowman A. B., Yoo S. Y., Dantuma N. P. &amp; Zoghbi H. Y. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Hum Mol Genet 14, 679&#x2013;691 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15661755</ArticleId></ArticleIdList></Reference><Reference><Citation>Maynard C. J. et al. Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment. Proc. Natl. Acad. Sci. USA 106, 13986&#x2013;13991 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2729007</ArticleId><ArticleId IdType="pubmed">19666572</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto A. Hormonally induced neuronal plasticity in the adult motoneurons. Brain Res. Bull. 44, 539&#x2013;547 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9370222</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris J. A., Jordan C. L. &amp; Breedlove S. M. Sexual differentiation of the vertebrate nervous system. Nat. Neurosci. 7, 1034&#x2013;1039 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15452574</ArticleId></ArticleIdList></Reference><Reference><Citation>Kujawa K. A., Jacob J. M. &amp; Jones K. J. Testosterone regulation of the regenerative properties of injured rat sciatic motor neurons. J. Neurosci. Res. 35, 268&#x2013;273 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8350388</ArticleId></ArticleIdList></Reference><Reference><Citation>Marron T. U. et al. Androgen-induced neurite outgrowth is mediated by neuritin in motor neurones. J. Neurochem. 92, 10&#x2013;20 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15606892</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M. et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35, 843&#x2013;854 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12372280</ArticleId></ArticleIdList></Reference><Reference><Citation>Montie H. L. et al. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 18, 1937&#x2013;1950 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2678926</ArticleId><ArticleId IdType="pubmed">19279159</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedelsky N. B. et al. Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron 67, 936&#x2013;952 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3514079</ArticleId><ArticleId IdType="pubmed">20869592</ArticleId></ArticleIdList></Reference><Reference><Citation>Duvick L. et al. SCA1-like disease in mice expressing wild-type ataxin-1 with a serine to aspartic acid replacement at residue 776. Neuron 67, 929&#x2013;935 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2946945</ArticleId><ArticleId IdType="pubmed">20869591</ArticleId></ArticleIdList></Reference><Reference><Citation>Balk S. P. &amp; Knudsen K. E. AR, the cell cycle, and prostate cancer. Nucl Recept Signal 6, e001 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2254330</ArticleId><ArticleId IdType="pubmed">18301781</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindler M. et al. Disruption of nongenomic testosterone signaling in a model of spinal and bulbar muscular atrophy. Mol. Endocrinol. 26, 1102&#x2013;1116 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5416995</ArticleId><ArticleId IdType="pubmed">22570336</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzolo I. et al. Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity. Hum. Mol. Genet. 16, 1593&#x2013;1603 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17470458</ArticleId></ArticleIdList></Reference><Reference><Citation>Walcott J. L. &amp; Merry D. E. Ligand promotes intranuclear inclusions in a novel cell model of spinal and bulbar muscular atrophy. J. Biol. Chem. 277, 50855&#x2013;50859 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12388541</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene L. A. Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium. J. Cell. Biol. 78, 747&#x2013;755 (1978).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2110184</ArticleId><ArticleId IdType="pubmed">701359</ArticleId></ArticleIdList></Reference><Reference><Citation>Lustig R. H., Hua P., Smith L. S., Wang C. &amp; Chang C. An in vitro model for the effects of androgen on neurons employing androgen receptor-transfected PC12 cells. Mol. Cell. Neurosci. 5, 587&#x2013;596 (1994).</Citation><ArticleIdList><ArticleId IdType="pubmed">7704433</ArticleId></ArticleIdList></Reference><Reference><Citation>de Launoit Y., Dauvois S., Dufour M., Simard J. &amp; Labrie F. Inhibition of cell cycle kinetics and proliferation by the androgen 5 alpha-dihydrotestosterone and antiestrogen N,n-butyl-N-methyl-11-[16&#x2032; alpha-chloro-3,17 beta-dihydroxy-estra-1,3&#x2032;,5&#x2032;-(10&#x2032;)triene-7&#x2032; alpha-yl] undecanamide in human breast cancer ZR-75-1 cells. Cancer Res. 51, 2797&#x2013;2802 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">2032219</ArticleId></ArticleIdList></Reference><Reference><Citation>Greeve M. A., Allan R. K., Harvey J. M. &amp; Bentel J. M. Inhibition of MCF-7 breast cancer cell proliferation by 5alpha-dihydrotestosterone; a role for p21(Cip1/Waf1). J. Mol. Endocrinol. 32, 793&#x2013;810 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15171713</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsihlias J. et al. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells. Oncogene 19, 670&#x2013;679 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10698512</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendzel M. J. et al. Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106, 348&#x2013;360 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9362543</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters J. M. The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat. Rev. Mol. Cell. Biol. 7, 644&#x2013;656 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16896351</ArticleId></ArticleIdList></Reference><Reference><Citation>Merry D. E., Kobayashi Y., Bailey C. K., Taye A. A. &amp; Fischbeck K. H. Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 7, 693&#x2013;701 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9499423</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J. P. et al. Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum. Mol. Genet. 12, 749&#x2013;757 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12651870</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzolo I. et al. Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron 63, 316&#x2013;328 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2735765</ArticleId><ArticleId IdType="pubmed">19679072</ArticleId></ArticleIdList></Reference><Reference><Citation>Donzelli M. et al. Dual mode of degradation of Cdc25 A phosphatase. EMBO J. 21, 4875&#x2013;4884 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC126287</ArticleId><ArticleId IdType="pubmed">12234927</ArticleId></ArticleIdList></Reference><Reference><Citation>Harmey D., Smith A., Simanski S., Moussa C. Z. &amp; Ayad N. G. The anaphase promoting complex induces substrate degradation during neuronal differentiation. J. Biol. Chem. 284, 4317&#x2013;4323 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19047054</ArticleId></ArticleIdList></Reference><Reference><Citation>Glotzer M., Murray A. W. &amp; Kirschner M. W. Cyclin is degraded by the ubiquitin pathway. Nature 349, 132&#x2013;138 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">1846030</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett E. J., Bence N. F., Jayakumar R. &amp; Kopito R. R. Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol. Cell 17, 351&#x2013;365 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15694337</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantuma N. P., Lindsten K., Glas R., Jellne M. &amp; Masucci M. G. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells. Nat. Biotechnol. 18, 538&#x2013;543 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10802622</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatchel J. R. &amp; Zoghbi H. Y. Diseases of unstable repeat expansion: mechanisms and common principles. Nat. Rev. Genet. 6, 743&#x2013;755 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16205714</ArticleId></ArticleIdList></Reference><Reference><Citation>Konishi Y., Stegmuller J., Matsuda T., Bonni S. &amp; Bonni A. Cdh1-APC controls axonal growth and patterning in the mammalian brain. Science 303, 1026&#x2013;1030 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14716021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasorella A. et al. Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth. Nature 442, 471&#x2013;474 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16810178</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi E., Dial J. M., Jeong D. E. &amp; Hall M. C. Unique D box and KEN box sequences limit ubiquitination of Acm1 and promote pseudosubstrate inhibition of the anaphase-promoting complex. J. Biol. Chem. 283, 23701&#x2013;23710 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3259782</ArticleId><ArticleId IdType="pubmed">18596038</ArticleId></ArticleIdList></Reference><Reference><Citation>Enquist-Newman M., Sullivan M. &amp; Morgan D. O. Modulation of the mitotic regulatory network by APC-dependent destruction of the Cdh1 inhibitor Acm1. Mol. Cell 30, 437&#x2013;446 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2494983</ArticleId><ArticleId IdType="pubmed">18498748</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller J. J. et al. Emi1 stably binds and inhibits the anaphase-promoting complex/cyclosome as a pseudosubstrate inhibitor. Genes Dev. 20, 2410&#x2013;2420 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1560415</ArticleId><ArticleId IdType="pubmed">16921029</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazemi-Esfarjani P., Trifiro M. A. &amp; Pinsky L. Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum. Mol. Genet. 4, 523&#x2013;527 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">7633399</ArticleId></ArticleIdList></Reference><Reference><Citation>Mhatre A. N. et al. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nat. Genet. 5, 184&#x2013;188 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8252045</ArticleId></ArticleIdList></Reference><Reference><Citation>Tut T. G., Ghadessy F. J., Trifiro M. A., Pinsky L. &amp; Yong E. L. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J. Clin. Endocrinol. Metab. 82, 3777&#x2013;3782 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9360540</ArticleId></ArticleIdList></Reference><Reference><Citation>Vismara G. et al. Androgens inhibit androgen receptor promoter activation in motor neurons. Neurobiol. Dis. 33, 395&#x2013;404 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19100835</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegmuller J. &amp; Bonni A. Moving past proliferation: new roles for Cdh1-APC in postmitotic neurons. Trends Neurosci. 28, 596&#x2013;601 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16168498</ArticleId></ArticleIdList></Reference><Reference><Citation>Meriggioli M. N. &amp; Rowin J. Fatigue and abnormal neuromuscular transmission in Kennedy&#x2019;s disease. Muscle Nerve 27, 249&#x2013;251 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12548535</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan S. et al. Mitochondrial abnormalities in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 18, 27&#x2013;42 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2644643</ArticleId><ArticleId IdType="pubmed">18824496</ArticleId></ArticleIdList></Reference><Reference><Citation>Su S. et al. Mitochondrial DNA damage in spinal and bulbar muscular atrophy patients and carriers. Clin. Chim. Acta 411, 626&#x2013;630 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20035733</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes C. J. et al. Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron 82, 295&#x2013;307 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4096235</ArticleId><ArticleId IdType="pubmed">24742458</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman A. P. et al. Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep. 7, 774&#x2013;784 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4356525</ArticleId><ArticleId IdType="pubmed">24746732</ArticleId></ArticleIdList></Reference><Reference><Citation>Monks D. A. et al. Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc. Natl. Acad. Sci. USA 104, 18259&#x2013;18264 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2084330</ArticleId><ArticleId IdType="pubmed">17984063</ArticleId></ArticleIdList></Reference><Reference><Citation>Soraru G. et al. Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. J. Neurol. Sci. 264, 100&#x2013;105 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">17854832</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp M. Q. et al. Impaired motoneuronal retrograde transport in two models of SBMA implicates two sites of androgen action. Hum. Mol. Genet. 20, 4475&#x2013;4490 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196895</ArticleId><ArticleId IdType="pubmed">21873607</ArticleId></ArticleIdList></Reference><Reference><Citation>Oki K. et al. Contractile dysfunction in muscle may underlie androgen-dependent motor dysfunction in spinal bulbar muscular atrophy. J. Appl. Physiol. (1985) 118, 941&#x2013;952 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4385878</ArticleId><ArticleId IdType="pubmed">25663674</ArticleId></ArticleIdList></Reference><Reference><Citation>Juo P. &amp; Kaplan J. M. The anaphase-promoting complex regulates the abundance of GLR-1 glutamate receptors in the ventral nerve cord of C. elegans. Curr. Biol. 14, 2057&#x2013;2062 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15556870</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L. et al. Anaphase-promoting complex/cyclosome controls HEC1 stability. Cell. Prolif. 44, 1&#x2013;9 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6496518</ArticleId><ArticleId IdType="pubmed">21199005</ArticleId></ArticleIdList></Reference><Reference><Citation>van Roessel P., Elliott D. A., Robinson I. M., Prokop A. &amp; Brand A. H. Independent regulation of synaptic size and activity by the anaphase-promoting complex. Cell 119, 707&#x2013;718 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15550251</ArticleId></ArticleIdList></Reference><Reference><Citation>Holterhus P. M., Piefke S. &amp; Hiort O. Anabolic steroids, testosterone-precursors and virilizing androgens induce distinct activation profiles of androgen responsive promoter constructs. J. Steroid Biochem. Mol. Biol. 82, 269&#x2013;275 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12589933</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>